BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31321589)

  • 1. Factors related to the quality of life in patients with bone metastases.
    Shinoda Y; Sawada R; Yoshikawa F; Oki T; Hirai T; Kobayashi H; Matsudaira K; Oka H; Tanaka S; Kawano H; Haga N
    Clin Exp Metastasis; 2019 Oct; 36(5):441-448. PubMed ID: 31321589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
    Bedard G; Zeng L; Poon M; Lam H; Lauzon N; Chow E
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):118-23. PubMed ID: 23551978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
    Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
    Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].
    Satoh T; Kobayashi K; Hori T; Iida S; Sato A; Ishiguro H; Chow E; Shimozuma K
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1507-12. PubMed ID: 20716876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
    Popovic M; Nguyen J; Chen E; Di Giovanni J; Zeng L; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Apr; 12(2):213-9. PubMed ID: 22458622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for overall quality of life in patients with advanced cancer.
    Cramarossa G; Chow E; Zhang L; Bedard G; Zeng L; Sahgal A; Vassiliou V; Satoh T; Foro P; Ma BB; Chie WC; Chen E; Lam H; Bottomley A
    Support Care Cancer; 2013 Jun; 21(6):1709-16. PubMed ID: 23338229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing health related quality of life in cancer patients with bone metastases.
    Wong E; Chow E; Zhang L; Bedard G; Lam K; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    J Palliat Med; 2013 Aug; 16(8):915-21. PubMed ID: 23819731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
    Chow E; Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):461-5. PubMed ID: 19817529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the EORTC QLQ-BM22 Module Using Rasch Modeling and Confirmatory Factor Analysis across Countries: a Comprehensive Psychometric Evaluation in Patients with Bone Metastases.
    Lin CY; Pakpour AH
    Asian Pac J Cancer Prev; 2016; 17(3):1405-10. PubMed ID: 27039780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy.
    Caissie A; Culleton S; Nguyen J; Zhang L; Zeng L; Holden L; Dennis K; Chan E; Jon F; Tsao M; Danjoux C; Sahgal A; Barnes E; Koo K; Chow E
    Support Care Cancer; 2012 Apr; 20(4):841-8. PubMed ID: 21538099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
    McDonald R; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar R; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
    Support Care Cancer; 2016 Dec; 24(12):4871-4878. PubMed ID: 27465049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
    Zeng L; Chow E; Bedard G; Zhang L; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e337-42. PubMed ID: 22763028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.
    Lee YJ; Suh SY; Choi YS; Shim JY; Seo AR; Choi SE; Ahn HY; Yim E
    Support Care Cancer; 2014 Jul; 22(7):1941-8. PubMed ID: 24577883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
    Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
    Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Cohabitants Reliably Complete Questionnaires for Patients in a Terminal Cancer Stage when Assessing Quality of Life, Pain, Depression, and Anxiety?
    Groot OQ; Paulino Pereira NR; Bongers MER; Ogink PT; Newman ET; Verlaan JJ; Raskin KA; Lozano-Calderon SA; Schwab JH
    Clin Orthop Relat Res; 2021 Apr; 479(4):792-801. PubMed ID: 33165035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases.
    Caissie A; Zeng L; Nguyen J; Zhang L; Jon F; Dennis K; Holden L; Culleton S; Koo K; Tsao M; Barnes E; Danjoux C; Sahgal A; Simmons C; Chow E
    Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):125-33. PubMed ID: 21917431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Quality of Life Using EORTC QLQ-BM22 in Patients with Bone Metastases after Treatment with Magnetic Resonance Guided Focused Ultrasound.
    Chen ZQ; Wang CR; Ma XJ; Sun W; Shen JK; Sun MX; Fu ZZ; Hua YQ; Cai ZD
    Orthop Surg; 2018 Aug; 10(3):264-271. PubMed ID: 30019516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.